Ixico Notes Role in US FDA Nod for New Alzheimer's Disease Biomarker Test

Published on 2025-06-10 at 05:12

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about IXICO plc

Ixico expects revenue growth will continue into 2026	02:33am	RE
Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test	06-10	AN
IXICO plc Announces FDA Clearance of New Alzheimer's Disease Blood Based Diagnostic Biomarker	06-10	CI
Ixico Notes Role in US FDA Nod for New Alzheimer's Disease Biomarker Test	06-10	MT
Ixico Assists First FDA Clearance Of Alzheimer's Diagnostic Biomarker	06-10	RE
IXICO plc, H1 2025 Earnings Call, May 20, 2025	05-21
IXICO plc Reports Earnings Results for the Half Year Ended March 31, 2025	05-20	CI
Ixico shares up amid positive outlook as interim loss narrows	05-20	AN
Earnings Flash (IXI.L) IXICO Reports Fiscal H1 Revenue GBP3.2M	05-20	MT
Earnings Flash (IXI.L) IXICO Posts Fiscal H1 Loss GBX-1.11	05-20	MT
IXICO Posts H1 Rev Up 26% To 3.2 Mln Stg	04-16	RE
Ixico plc Provides Revenue Guidance for the Year Ending 31 March 2025	04-16	CI
Ixico Secures Two New Contracts for Alzheimer's, Huntington's Disease Imaging Analysis	02-27	MT
IXICO plc Wins in Alzheimer's and Huntington's Disease	02-27	CI
Ixico Bags Imaging Services Deal with US Client	12-10	MT
IXICO plc Wins US Client Clinical Trial Contract	12-10	CI
IXICO plc, 2024 Earnings Call, Dec 05, 2024	12-05
IXICO plc, 2024 Earnings Call, Dec 04, 2024	12-04
IXICO plc Reports Earnings Results for the Full Year Ended September 30, 2024	12-04	CI
Medical Imaging Group Ixico Completes Retail Offer	24-10-15	MT
Ixico raises GBP4 million in equity raise at premium price	24-10-09	AN
Ixico Conditionally Raises GBP4 Million via Fundraising	24-10-09	MT
Ixico to Raise Equity via Share Placement, Subscription; Plans Retail Offer	24-10-09	MT
Ixico shares soar as company eyes stronger revenue in second half	24-08-14	AN
Stocks stay upbeat ahead of US CPI data	24-08-14	AN